Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain

The most common neurological complication in patients receiving successful combination antiretroviral therapy (cART) is peripheral neuropathic pain. Data show that distal symmetric polyneuropathy (DSP) also develops along with murine acquired immunodeficiency syndrome (MAIDS) after infection with th...

Full description

Saved in:
Bibliographic Details
Main Authors: Wen S. Sheng, Priyanka Chauhan, Shuxian Hu, Sujata Prasad, James R. Lokensgard
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Pain Research and Management
Online Access:http://dx.doi.org/10.1155/2019/1260353
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558059652644864
author Wen S. Sheng
Priyanka Chauhan
Shuxian Hu
Sujata Prasad
James R. Lokensgard
author_facet Wen S. Sheng
Priyanka Chauhan
Shuxian Hu
Sujata Prasad
James R. Lokensgard
author_sort Wen S. Sheng
collection DOAJ
description The most common neurological complication in patients receiving successful combination antiretroviral therapy (cART) is peripheral neuropathic pain. Data show that distal symmetric polyneuropathy (DSP) also develops along with murine acquired immunodeficiency syndrome (MAIDS) after infection with the LP-BM5 murine retrovirus mixture. Links between cannabinoid receptor 2 (CB2R) and peripheral neuropathy have been established in animal models using nerve transection, chemotherapy-induced pain, and various other stimuli. Diverse types of neuropathic pain respond differently to standard drug intervention, and little is currently known regarding the effects of modulation through CB2Rs. In this study, we evaluated whether treatment with the exogenous synthetic CB2R agonists JWH015, JWH133, Gp1a, and HU308 controls neuropathic pain and neuroinflammation in animals with chronic retroviral infection. Hind-paw mechanical hypersensitivity in CB2R agonist-treated versus untreated animals was assessed using the MouseMet electronic von Frey system. Multicolor flow cytometry was used to determine the effects of CB2R agonists on macrophage activation and T-lymphocyte infiltration into dorsal root ganglia (DRG) and lumbar spinal cord (LSC). Results demonstrated that, following weekly intraperitoneal injections starting at 5 wk p.i., JWH015, JWH133, and Gp1a, but not HU308 (5 mg/kg), significantly ameliorated allodynia when assessed 2 h after ligand injection. However, these same agonists (2x/wk) did not display antiallodynic effects when mechanical sensitivity was assessed 24 h after ligand injection. Infection-induced macrophage activation and T-cell infiltration into the DRG and LSC were observed at 12 wk p.i., but this neuroinflammation was not affected by treatment with any CB2R agonist. Activation of JAK/STAT3 has been shown to contribute to development of neuropathic pain in the LSC and pretreatment of primary murine microglia (2 h) with JWH015-, JWH133-, or Gp1a-blocked IFN-gamma-induced phosphorylation of STAT1 and STAT3. Taken together, these data show that CB2R agonists demonstrate acute, but not long-term, antiallodynic effects on retrovirus infection-induced neuropathic pain.
format Article
id doaj-art-b4f2ef237ad742e6bc095300abc63009
institution Kabale University
issn 1203-6765
1918-1523
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Pain Research and Management
spelling doaj-art-b4f2ef237ad742e6bc095300abc630092025-02-03T01:33:25ZengWileyPain Research and Management1203-67651918-15232019-01-01201910.1155/2019/12603531260353Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic PainWen S. Sheng0Priyanka Chauhan1Shuxian Hu2Sujata Prasad3James R. Lokensgard4Neurovirology Laboratory, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USANeurovirology Laboratory, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USANeurovirology Laboratory, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USANeurovirology Laboratory, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USANeurovirology Laboratory, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USAThe most common neurological complication in patients receiving successful combination antiretroviral therapy (cART) is peripheral neuropathic pain. Data show that distal symmetric polyneuropathy (DSP) also develops along with murine acquired immunodeficiency syndrome (MAIDS) after infection with the LP-BM5 murine retrovirus mixture. Links between cannabinoid receptor 2 (CB2R) and peripheral neuropathy have been established in animal models using nerve transection, chemotherapy-induced pain, and various other stimuli. Diverse types of neuropathic pain respond differently to standard drug intervention, and little is currently known regarding the effects of modulation through CB2Rs. In this study, we evaluated whether treatment with the exogenous synthetic CB2R agonists JWH015, JWH133, Gp1a, and HU308 controls neuropathic pain and neuroinflammation in animals with chronic retroviral infection. Hind-paw mechanical hypersensitivity in CB2R agonist-treated versus untreated animals was assessed using the MouseMet electronic von Frey system. Multicolor flow cytometry was used to determine the effects of CB2R agonists on macrophage activation and T-lymphocyte infiltration into dorsal root ganglia (DRG) and lumbar spinal cord (LSC). Results demonstrated that, following weekly intraperitoneal injections starting at 5 wk p.i., JWH015, JWH133, and Gp1a, but not HU308 (5 mg/kg), significantly ameliorated allodynia when assessed 2 h after ligand injection. However, these same agonists (2x/wk) did not display antiallodynic effects when mechanical sensitivity was assessed 24 h after ligand injection. Infection-induced macrophage activation and T-cell infiltration into the DRG and LSC were observed at 12 wk p.i., but this neuroinflammation was not affected by treatment with any CB2R agonist. Activation of JAK/STAT3 has been shown to contribute to development of neuropathic pain in the LSC and pretreatment of primary murine microglia (2 h) with JWH015-, JWH133-, or Gp1a-blocked IFN-gamma-induced phosphorylation of STAT1 and STAT3. Taken together, these data show that CB2R agonists demonstrate acute, but not long-term, antiallodynic effects on retrovirus infection-induced neuropathic pain.http://dx.doi.org/10.1155/2019/1260353
spellingShingle Wen S. Sheng
Priyanka Chauhan
Shuxian Hu
Sujata Prasad
James R. Lokensgard
Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
Pain Research and Management
title Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
title_full Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
title_fullStr Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
title_full_unstemmed Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
title_short Antiallodynic Effects of Cannabinoid Receptor 2 (CB2R) Agonists on Retrovirus Infection-Induced Neuropathic Pain
title_sort antiallodynic effects of cannabinoid receptor 2 cb2r agonists on retrovirus infection induced neuropathic pain
url http://dx.doi.org/10.1155/2019/1260353
work_keys_str_mv AT wenssheng antiallodyniceffectsofcannabinoidreceptor2cb2ragonistsonretrovirusinfectioninducedneuropathicpain
AT priyankachauhan antiallodyniceffectsofcannabinoidreceptor2cb2ragonistsonretrovirusinfectioninducedneuropathicpain
AT shuxianhu antiallodyniceffectsofcannabinoidreceptor2cb2ragonistsonretrovirusinfectioninducedneuropathicpain
AT sujataprasad antiallodyniceffectsofcannabinoidreceptor2cb2ragonistsonretrovirusinfectioninducedneuropathicpain
AT jamesrlokensgard antiallodyniceffectsofcannabinoidreceptor2cb2ragonistsonretrovirusinfectioninducedneuropathicpain